CN111655272A - 活化肿瘤浸润淋巴细胞(TILs)的方法 - Google Patents

活化肿瘤浸润淋巴细胞(TILs)的方法 Download PDF

Info

Publication number
CN111655272A
CN111655272A CN201980007599.2A CN201980007599A CN111655272A CN 111655272 A CN111655272 A CN 111655272A CN 201980007599 A CN201980007599 A CN 201980007599A CN 111655272 A CN111655272 A CN 111655272A
Authority
CN
China
Prior art keywords
tumor
cancer
tils
infiltrating lymphocytes
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980007599.2A
Other languages
English (en)
Chinese (zh)
Inventor
路孔明
郭明良
杨瑷祯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbio Co Ltd
Original Assignee
Microbio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbio Co Ltd filed Critical Microbio Co Ltd
Publication of CN111655272A publication Critical patent/CN111655272A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201980007599.2A 2018-01-09 2019-01-09 活化肿瘤浸润淋巴细胞(TILs)的方法 Pending CN111655272A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862615300P 2018-01-09 2018-01-09
US62/615,300 2018-01-09
PCT/CN2019/070944 WO2019137384A1 (en) 2018-01-09 2019-01-09 Method of activating tumor-infiltrating lymphocytes (tils)

Publications (1)

Publication Number Publication Date
CN111655272A true CN111655272A (zh) 2020-09-11

Family

ID=67139037

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980007599.2A Pending CN111655272A (zh) 2018-01-09 2019-01-09 活化肿瘤浸润淋巴细胞(TILs)的方法

Country Status (6)

Country Link
US (1) US11179425B2 (cg-RX-API-DMAC7.html)
EP (2) EP3737395A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021517587A (cg-RX-API-DMAC7.html)
CN (1) CN111655272A (cg-RX-API-DMAC7.html)
TW (1) TWI817977B (cg-RX-API-DMAC7.html)
WO (1) WO2019137384A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119868398A (zh) * 2018-06-14 2025-04-25 株式会社明治 用于促进免疫检查点抑制疗法的组合物
JP7856975B2 (ja) 2022-09-12 2026-05-12 賢一郎 蓮見 抗腫瘍免疫応答増強剤

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003026582A (ja) * 2001-03-21 2003-01-29 Microbio Co Ltd 癌の抑制、感染症の低下、および健康の促進に用いる組成物
JP2003335695A (ja) * 2002-05-17 2003-11-25 Nippon Bio Kk 大豆発酵物よりなる免疫増強剤、抗腫瘍剤、加工食品および大豆発酵物の製造方法
US20130302380A1 (en) * 2010-12-28 2013-11-14 Daisuke Fujiwara Agent for inducing interferon production containing lactic acid bacteria
CN104415298A (zh) * 2013-09-06 2015-03-18 中天生物科技股份有限公司 用于制造供化疗癌症患者使用的辅助治疗剂的组合物
US20150202291A1 (en) * 2013-11-05 2015-07-23 Cognate Bioservices, Inc. Combinations of checkpoint inhibitors and therapeutics to treat cancer
WO2017167213A1 (en) * 2016-03-30 2017-10-05 Microbio Co., Ltd. Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota
WO2017174649A1 (en) * 2016-04-05 2017-10-12 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii Method for preparing lymphocytes capable of infiltrating a solid tumor, lymphocytes obtainable by said method and uses thereof
CN112779217A (zh) * 2021-03-29 2021-05-11 复旦大学附属中山医院 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60134386D1 (de) 2001-03-21 2008-07-24 Microbio Co Ltd Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt
TWI252759B (en) 2002-07-05 2006-04-11 Microbio Co Ltd Method of using fermented glycine max (L.) extract for enhancing natural killer cell activity
CN100352459C (zh) 2004-07-15 2007-12-05 中天生物科技股份有限公司 发酵大豆萃取液在制备药物中的应用
SG187554A1 (en) 2010-07-20 2013-03-28 Microbio Co Ltd Use of a fermented soy extract for manufacture of a prebiotic composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003026582A (ja) * 2001-03-21 2003-01-29 Microbio Co Ltd 癌の抑制、感染症の低下、および健康の促進に用いる組成物
JP2003335695A (ja) * 2002-05-17 2003-11-25 Nippon Bio Kk 大豆発酵物よりなる免疫増強剤、抗腫瘍剤、加工食品および大豆発酵物の製造方法
US20130302380A1 (en) * 2010-12-28 2013-11-14 Daisuke Fujiwara Agent for inducing interferon production containing lactic acid bacteria
CN104415298A (zh) * 2013-09-06 2015-03-18 中天生物科技股份有限公司 用于制造供化疗癌症患者使用的辅助治疗剂的组合物
US20150202291A1 (en) * 2013-11-05 2015-07-23 Cognate Bioservices, Inc. Combinations of checkpoint inhibitors and therapeutics to treat cancer
WO2017167213A1 (en) * 2016-03-30 2017-10-05 Microbio Co., Ltd. Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota
WO2017174649A1 (en) * 2016-04-05 2017-10-12 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii Method for preparing lymphocytes capable of infiltrating a solid tumor, lymphocytes obtainable by said method and uses thereof
CN112779217A (zh) * 2021-03-29 2021-05-11 复旦大学附属中山医院 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法

Also Published As

Publication number Publication date
EP3737395A4 (en) 2021-09-29
US11179425B2 (en) 2021-11-23
TW201938181A (zh) 2019-10-01
EP4755455A2 (en) 2026-06-10
TWI817977B (zh) 2023-10-11
JP2021517587A (ja) 2021-07-26
EP3737395A1 (en) 2020-11-18
US20190209623A1 (en) 2019-07-11
JP2024050573A (ja) 2024-04-10
WO2019137384A1 (en) 2019-07-18

Similar Documents

Publication Publication Date Title
CN110496140B (zh) 脆弱拟杆菌或阿克曼粘细菌在制备用于预防或治疗肿瘤的药物中的应用
JP7594826B2 (ja) ラクトバチルス・プランタルムgb104株及びそれを含むがんの予防又は処置のための組成物
Marinelli et al. Probiotic species in the modulation of the anticancer immune response
JP6869994B2 (ja) Nk細胞培養用培地添加キット、及びキットを用いるnk細胞培養方法
CN109966320B (zh) 凝结芽孢杆菌在制备诱导抗肿瘤免疫及免疫检查点抑制剂增敏制剂中的应用
KR20090127973A (ko) 자기활성화 림프구 배양 방법
CN114540229A (zh) 一种增强免疫检查点抑制剂治疗效应的副干酪乳杆菌株及其应用
JP2024050573A (ja) 腫瘍浸潤リンパ球(tils)を活性化する方法
CN116782948A (zh) 包含长双歧杆菌rapo(kctc13773bp)的用于预防或治疗癌症的组合物
CN112334141A (zh) 用于促进免疫检查点抑制疗法的组合物
CN115806893B (zh) 普通拟杆菌及其组合物在辅助癌症免疫治疗中的应用
WO2024140860A1 (zh) 克里斯滕森菌或包含其的组合物在预防或治疗肿瘤中的用途以及包含其的药物
WO2025036176A1 (zh) 一株肠道菌及其在抗肿瘤免疫治疗中的应用
WO2023134203A1 (zh) 脆弱拟杆菌及其两性离子荚膜多糖在制备用于治疗呼吸系统肿瘤药物中的应用
CN117503802A (zh) Ac菌在抗肿瘤免疫治疗中的应用
CN117018036B (zh) 巨球形菌属细菌在制备治疗癌症的药物中的应用
CN110448681B (zh) 一种用于恶性肿瘤免疫治疗的联合药物
CN110734888B (zh) Tim3人源单链抗体融合基因转化乳酸菌及其应用
KR102143856B1 (ko) 대식세포에 물질을 송달하는 담체
CN110643623B (zh) 人可溶性cd80融合基因转化乳酸菌及其应用
CN109432116A (zh) 黄芪皂苷ⅲ在制备肿瘤免疫治疗药物中的用途
JP2023539640A (ja) 抗腫瘍細菌株、並びにそれを利用した組成物及びその方法
KR20240123764A (ko) 락토바실러스 플란타룸 균주 및 면역세포의 병용 요법을 이용한 암 예방 또는 치료용 조성물
KR20230121536A (ko) 락토바실러스 플란타룸 균주 및 항암제를 포함하는 병용 요법을 이용한 암 예방 또는 치료용 조성물
JP2025529567A (ja) ラクトバチルス・プランタルム菌株を含む腸内代謝産物組成を改善するための組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200911